secwatch.observer — SEC 8-K summary
======================================

Issuer:     ANAPTYSBIO, INC (ANAB)
CIK:        0001370053
Form:       8-K
Filed at:   2025-02-19T23:59:59+00:00
Accession:  0001370053-25-000014
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

AnaptysBio updates corporate investor presentation; details not available from filing
--------------------------------------------------------------------------------

- Filing indicates updated February 2025 corporate presentation, but full content not provided in extract.
- No specific financial or pipeline updates disclosed in the filing text or the partial exhibit.
- Presentation typically covers strategic overview; no material numbers or events are reported.
- Investors should refer to the full presentation on the company website for details.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1370053/000137005325000014/0001370053-25-000014-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1370053/000137005325000014/anab-20250219.htm
  HTML page:      https://secwatch.observer/filing/0001370053-25-000014

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer